Kelly Copeland

Kelly Copeland is an experienced professional in the pharmaceutical industry, with a career spanning multiple companies and roles. With a Master's degree in Health Services Administration from the University of Michigan, Kelly has held various leadership positions such as SVP of Operations & Product Strategy at Uniquity Bio and Nexstone Immunology, as well as VP of Commercial Development & CMC at NexEos Bio. With a strong background in product strategy and marketing, Kelly has contributed significantly to the growth and success of companies like Onspira Therapeutics, Velicept Therapeutics, and Aclaris Therapeutics. With a wealth of experience and expertise, Kelly continues to make a significant impact in the industry.